Evaluation of the effect of intracavernous stem cell injection on the treatment of erectile dysfunction in diabetic patients

Clinical trial of the evaluation of the effect of intracavernous stem cell injection on the treatment of erectile dysfunction compared to control group in diabetic patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190517043609N1

Enrollment

Registered

2020-01-25

Start date

2019-09-22

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile dysfunction. Male erectile dysfunction

Interventions

Intervention 1: Intervention group: In the intervention group with local anesthesia, a tissue sample of about half a centimeter diameter without any need for suture was taken from each patient's oral

Eligibility

Sex/Gender

Male

Age

55 Years to 75 Years

Inclusion criteria

Inclusion criteria: Erectal dysfunction Diabetes Ages: 55-75 years

Exclusion criteria

Exclusion criteria: Hypertension Hyperlipidemia Obesity Low testosterone High prolactin Hypothyroidism Hyperthyroidism Impaired Luteinizing Hormone ( LH) Impaired Follicle Stimulating Hormone ( FSH)

Design outcomes

Primary

Measure	Time frame
Erectile function. Timepoint: 3 and 6 months after the injection. Method of measurement: Questionnaire IIEF5 (International Index of Erectile Dysfunction Inventory) and Patient Statement and Color Doppler Sonography.	—

Secondary

Measure	Time frame
. Timepoint: . Method of measurement: .	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahbobe Mirzaie

Kerman University of Medical Sciences

mirzaeimahboubeh@yahoo.com+98 34 3222 1600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026